Kestra Advisory Services »

Protalix Biotherapeutics shares owned by Kestra Advisory Services

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Kestra Advisory Services from 13F filings

Historical chart of Kestra Advisory Services investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Kestra Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Kestra Advisory Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $21k 12k 1.78
2023-09-30 $19k 12k 1.66
2023-06-30 $23k 12k 2.00

More positions owned by Kestra Advisory Services

Apple (AAPL)
Parker-Hannifin Corporation (PH)
Ishares Tr Msci Ac Asia Etf (IVV)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Small Cp Etf (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Small Cp Etf (VTI)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl A (BRK.B)
Vanguard Index Fds Small Cp Etf (VUG)
NVIDIA Corporation (NVDA)
First Tr Exchange-traded Rba Indl Etf (RDVY)
Vanguard Index Fds Small Cp Etf (VTV)
Ishares Tr Msci Ac Asia Etf (IJR)

View all positions for Kestra Advisory Services

Top funds holding Protalix Biotherapeutics

BlackRock
Geode Capital Management
GSA Capital Partners
Northern Trust
Vanguard Group
Nuveen Asset Management
Bridgeway Capital Management
Bank of New York Mellon
Morgan Stanley
Charles Schwab Investment Management
Bank of America Corporation
Susquehanna International
Goldman Sachs Group
Two Sigma Securities
Barclays

View all funds holding Protalix Biotherapeutics